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Abstract In situ hybridization and immunohistochemical ex-
aminations of surgically resected specimens of human hyperplas-
tic tonsils showed that macrophages in the germinal center and
mast cells in the parafollicular and interfollicular areas expressed
the transcript and protein of endothelin (ET)-1, but not ET-2 and
ET-3. The macrophages appeared to be activated, since they
possessed significant amounts of inducible nitric oxide synthase.
None of these expressions was observed in normal tonsil. Our
results suggest that the over-production of ET-1 by macrophages
and mast cells may be involved in the pathogenesis of
hyperplastic tonsils.
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1. Introduction
The tonsils are the ¢rst line of defense against invasion of
viruses, microbes, and irritants into the airways. Recurrent
tonsillitis and reactive tonsil hypertrophy are sometimes a
serious clinical problem even in healthy subjects, and tonsil-
lectomy is inevitable for patients with serious symptoms, such
as recurrent infections, sleep disturbance, and failure to gain
weight. The pathological micro£ora is the primary cause of
recurrent tonsillitis ; however, the mechanism by which tonsils
progressively become hyperplastic is unknown. In£ammatory
and immune responses of tonsils are regulated by complex
cytokine and chemokine networks, and the Th2 pro¢le of
cytokines was reported to be predominant in recurrent tonsil-
litis [1].
In this study, we focused on the expression of endothelin
(ET)-1 in hyperplastic tonsils. ET-1 exerts a variety of bio-
logical actions, including vasocontraction [2], neurotransmis-
sion [3], and cell proliferation [4,5], some of which are sup-
posed to contribute to the development and progression of
in£ammatory processes. In fact, synthesis and release of ET-
1 were reported to be up-regulated during the initial phase of
airway in£ammation, leading to proin£ammatory e¡ects in
bronchial asthma [6]. ET-1 may also participate in the hyper-
responsiveness of tonsils ; however, ET-1 expression in normal
and hyperplastic tonsils has never been studied in detail.
In normal human tonsil, the ET-1 transcript was scarcely
detected by in situ hybridization and immunohistochemical
techniques. However, surgically resected specimens of hyper-
plastic tonsils contained high levels of the transcript and pro-
tein in macrophages of germinal centers and in mast cells of
parafollicular and interfollicular areas, suggesting a pathogen-
ic role of ET-1 in hyperplastic tonsils.
2. Materials and methods
2.1. Tissues preparation
The present study was approved by the Ethics Committee, Univer-
sity of Tokushima. Four male and two female patients with hyper-
plastic tonsils (age 25^46) understood the purpose and protocol of this
study and gave written consent to o¡er tonsil tissues after surgical
resection. For in situ hybridization, these surgically resected tonsils
were immediately ¢xed with ice-cold Bouin solution without acetic
acid for 12 h. After ¢xation, these tissues were embedded in para⁄n.
Tissue slices of normal human tonsil, embedded in para⁄n, were
purchased from DAKO (Glostrup, Denmark).
2.2. In situ hybridization
Template DNA for cRNA synthesis was prepared by the polym-
erase chain reaction from the human ET-1 cDNA with the follow-
ing primers: sense, T7 RNA promoter site (5P-GGATCCTAATA-
CGACTCACTATAGGGCCGCCGCGTGGCCTGCAGA-3P); anti-
sense, SP6 RNA promoter site (5P-GATACGATTTAGGTGACA-
CTATAGTGAAAGAAGAGACCAAG-3P). The reaction was per-
formed in 35 cycles (5 min at 95‡C followed by 1 min at 95‡C,
1 min at 55‡C, and 1 min at 72‡C) in a DNA thermal cycler [7].
Digoxigenin (DIG)-labeled antisense or sense cRNA was generated
by in vitro transcription system from the above template DNA.
Both probes were synthesized by T7 or SP6 RNA polymerase using
DIG-UTP, according to the manufacturer’s recommended protocol
(Roche, Switzerland). The cRNA probes were hydrolyzed in 0.1 M
sodium carbonate (pH 10.2) at 60‡C for the appropriate time to give
150 bp. Hybridization and color development were carried out by the
previously described method [8] with minor modi¢cations.
RNase-pretreated sections were hybridized with the antisense
cRNA probe to detect non-speci¢c bindings, and the DIG-labeled
sense cRNA probe was used to determine the speci¢c hybridization
reaction.
2.3. Immunohistochemistry
For immunohistochemistry, serial sections (6 Wm thick) were de-
waxed in xylene and dehydrated in a graded series of ethanol. Endog-
enous peroxidase activity was inhibited by incubation with 0.6% hy-
drogen peroxide in methanol. The slides were incubated overnight at
4‡C with an antibody against anti-human iNOS (1:1000) (Wako
Chemical Co., Tokyo, Japan), human ET-1, ET-3 (3 Wg/ml) (IBL,
Fujioka, Japan), human big ET-2 (1:500) (Peptide Institute, Osaka,
Japan), human nuclear factor-UB components, p50 and p65 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA). After washing, the sam-
ples were incubated for 1 h at room temperature with a diluted second
antibody (biotinylated anti-rabbit IgG) and then treated with Extra
avidin-peroxidase (Sigma, St. Louis, MO, USA). Immunoreactive ma-
terials to these antibodies were visualized with Extra avidin-biotin-
peroxidase staining with 3,3-diaminobenzidine tetrahydrochloride
(DAB) (Dojin, Kumamoto, Japan) and 0.01% H2O2 as substrates.
The other slides were incubated overnight at 4‡C with macrophage
antibody (HAM56; Enzo Diagnostics, San Francisco, CA, USA).
They were treated for 1 h at room temperature with a diluted second
antibody (alkaline phosphatase-conjugated anti-mouse IgG+M+A)
(Zymed Lab. Inc., San Francisco, CA, USA), followed by treatment
with alkaline phosphatase substrate (fast blue RR and naphthol AS-
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MX phosphate). Tonsil sections were also stained with 0.1% (w/v)
alcian blue in 0.7 M HCl for 15 min at room temperature and
mounted in AQUATEX (Merck, Darmstadt, Germany).
3. Results
As shown in Fig. 1A, germinal centers of hypertrophic ton-
sils contained abundant ET-1 mRNA signals which were not
detected by the sense RNA (Fig. 1B). These strong signals
were not observed in germinal centers of normal tonsils
(Fig. 1E). Most cells in the centers of hyperplastic tonsils ex-
pressed ET-1 mRNA to varied extents, and cells expressing
extremely high levels of the ET-1 transcript (indicated by ar-
rows, Fig. 1C) were sporadically observed. Based on their
distribution, size, and shape, these cells were likely to be mac-
rophages. This was con¢rmed by immunohistochemical anal-
yses of the serial sections with an antibody against macro-
phages (HAM56). The distribution of HAM56-positive
macrophages (Fig. 1D) roughly coincided with that of the
large macrophage-like cells having strong ET-1 mRNA signals
(Fig. 1C).
The expression of ET-1 was also con¢rmed by immunohis-
tochemistry. Cells positive for immunoreactivities to the ET-1
antibody were observed in the centers of hyperplastic tonsils
(Fig. 2A), but not in normal tonsils (Fig. 2B). These cells
(shown by arrows in Fig. 2A) were con¢rmed to be macro-
phages by immunohistochemical examination of a serial sec-
tion with the anti-HAM56 antibody (data not shown). We
also examined whether the other ET isoforms were expressed
in hyperplastic tonsils. Signi¢cant amounts of immunoreactive
materials to big ET-2 (Fig. 2C) or ET-3 antibody (Fig. 2D)
were not detected.
The macrophages expressing ET-1 were characterized to be
activated cells, since they contained immunoreactive materials
to anti-iNOS antibody (Fig. 3A). In normal tonsil, the num-
ber of HAM56-positive macrophages, distributed in germinal
centers (Fig. 1F), was about 30% less than in hyperplastic
tonsil (Fig. 1D), and iNOS-expressing cells were not observed
in normal tonsil (Fig. 3B).
Although the ET-1 mRNA-expressing cells were distributed
mainly in the germinal centers of hypertrophic tonsils, small
cells expressing the transcript were scatteredly observed in the
Fig. 1. ET-1 expression in germinal centers of hyperplastic tonsils. A: Germinal centers and interfollicular areas of hyperplastic tonsil were
stained with the antisense cRNA probe of ET-1 mRNA. Abundant signals are located in the germinal centers. Magni¢cation U200. B: Germi-
nal centers of hyperplastic tonsil were stained with the sense probe of ET-1 mRNA. Magni¢cation U400. C: Germinal centers of hyperplastic
tonsil were stained with the antisense cRNA probe of ET-1 mRNA. Cells expressing strongly were sporadically observed in the germinal center
(arrows). Magni¢cation U400. D: Immunohistochemical detection of HAM56-positive macrophages in the germinal centers of hyperplastic ton-
sil (arrows). Fig. 1C,D and Fig. 3A were serial sections, and arrows indicate identical cells in the sections. Magni¢cation U400. E: Germinal
centers of normal tonsil were stained with the antisense cRNA probe of ET-1 mRNA. Magni¢cation U400. F: Immunohistochemical detection
of HAM56-positive macrophages in the germinal centers of normal tonsil. Magni¢cation U400.
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interfollicular spaces of hypertrophic tonsils (Fig. 4A), but not
in the normal tonsils (data not shown). These spindle-shaped
cells were identi¢ed as mast cells positive for alcian blue stain-
ing (Fig. 4B), and ET-1 immunoreactivities were also observed
in these cells (Fig. 4C).
4. Discussion
ET-1 is a member of the ET family of structurally related
21 amino acid peptide hormones [2,9]. ET-1 exerts numerous
biological actions and is widely distributed in di¡erent human
tissues, including the brain [10], lung [11], kidney [11], and
placenta [12].
In normal tonsils, resident macrophages in the germinal
centers did not possess signi¢cant amounts of iNOS protein,
and they expressed only low levels of the ET-1 mRNA. In
addition, the macrophages did not possess detectable amounts
of ET-1 protein. In hyperplastic tonsils, the number of macro-
phages in¢ltrated into the germinal centers increased, and they
appeared to be activated, since these cells contained higher
levels of iNOS protein. Immunohistochemical study with anti-
bodies against nuclear factor-UB components (p50 and p65)
showed that these factors translated into nuclei of macro-
phages to varied extents in hyperplastic tonsils, while nuclear
translocation was not observed in normal tonsil (data not
shown). Thus, hyperplastic tonsil contained activated macro-
phages that appeared to produce abundant ET-1 as well as
NO. Human lung macrophages, activated by lipopolysacchar-
ide or stimulated by phorbol diesters, were also shown to
markedly enhance synthesis and secretion of ET-1 [13], sug-
gesting an important role for ET-1 in the microenvironment
of tissue macrophages.
Activated tissue macrophages dramatically enhance or
newly induce secretions of biologically active products, includ-
Fig. 2. Expression of ET isoforms in hyperplastic tonsils. Hypertrophic (A,C,D) or normal tonsils (B) were subjected to immunohistochemical
analysis with the antibody against human ET-1 (A,B), big ET-2 (C), or human ET-3 (D), as described in Section 2. ET-1-positive cells are
shown by arrows. Magni¢cation U340.
Fig. 3. Expression of iNOS in hyperplastic tonsils. Comparable sections of the germinal centers of human hyperplastic tonsil (A) and normal
tonsil (B) were stained with anti-iNOS. The iNOS-positive cells can be detected in the germinal centers of hyperplastic tonsil (arrows). Magni¢-
cation U340.
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ing reactive oxygen metabolites, cytokines and other factors,
all of which are important mediators for in£ammatory and
immune responses. Enhanced secretion of superoxide anion
and NO produces more reactive metabolites, such as hydroxyl
radical and peroxynitrate [14,15]. These metabolites are well
known to cause cell and tissue damage that may result in
increased hyperresponsiveness of tonsil. Compared to these
oxygen intermediates and other cytokines, the exact meaning
of the over-production of ET-1 in the pathogenesis of hyper-
plastic tonsils is unknown. ET-1 exerts its biological action
through binding to distinct G protein-coupled receptors,
known as ETA and ETB receptor subtypes [16]. Identi¢cation
of speci¢c target cells for ET-1 and demonstration of ET-1-
dependent events are required to reveal a pathogenic role of
ET-1 in hyperplastic tonsils.
We also show that connective tissue mast cells in hyper-
plastic tonsils expressed ET-1 mRNA. Fureder et al. [17] re-
ported that the distribution of human tonsil mast cells was
localized in parafollicular and interfollicular areas, where they
exhibit functional and phenotypic properties that are similar
to lung or uterus mast cells, but not to skin mast cells. Con-
sidering the potent activities of mast cells to produce cyto-
kines or chemical mediators, distinct factors derived from
the mast cells are likely to be involved in the pathogenesis
of hyperplastic tonsil, and ET-1 might be one of the possible
mediators.
Our histological approach may provide only limited infor-
mation. However, to the best of our knowledge, the results of
this study provide the ¢rst evidence that activated macro-
phages in the germinal centers, as well as mast cells in the
parafollicular and interfollicular areas, contained high levels
of ET-1 mRNA and its protein, suggesting an important role
of ET-1 in the development and progression of hypertrophic
tonsil. Our results also imply the possibility that administra-
tion of speci¢c ET-1 receptor antagonists or iNOS inhibitors
may be a novel approach for treatment of intractable hyper-
plastic tonsil.
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Fig. 4. Expression of ET-1 in mast cells. Sequential sections were
stained with the antisense cRNA probe of ET-1 mRNA (A) and al-
cian blue (B). Mast cells can be detected in the interfollicular areas
(arrows indicate identical mast cells). ET-1 immunoreactivity was
also observed in mast cells (C) (shown by arrowheads). Magni¢ca-
tion U340.
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